Related Experiment Videos
Gamma knife surgery for glioblastoma multiforme
R Webster Crowley1, Nader Pouratian, Jason P Sheehan
1Department of Neurological Surgery, University of Virginia Health System, Charlottesville, Virginia 22908-0212, USA.
Neurosurgical Focus
|May 20, 2006
Summary
Gamma Knife Surgery (GKS) shows potential survival benefits for glioblastoma multiforme (GBM) management, despite mixed results from trials. Further review of GKS mechanisms and applications is needed for this aggressive brain tumor.
Area of Science:
- Neurosurgery
- Radiation Oncology
- Oncology
Background:
- Glioblastoma multiforme (GBM) remains challenging to treat, with limited survival improvements from standard therapies.
- Gamma Knife Surgery (GKS) is effective for various intracranial pathologies.
- The suitability of GKS for infiltrative GBM is debated due to its precise radiation delivery.
Purpose of the Study:
- To review the pathophysiological mechanisms of GKS.
- To explore the applications of GKS in glioblastoma multiforme management.
- To assess the potential survival benefit of GKS in GBM treatment.
Main Methods:
- Review of institutional series and clinical trial data on GKS for GBM.
- Analysis of tumor recurrence patterns relative to resection cavities.
- Examination of GKS radiobiology and technical considerations.
Main Results:
- Limited institutional data suggest GKS may improve survival in comprehensive GBM management.
- Tumor recurrence often occurs within a 2-cm margin of the resection cavity, a region potentially targeted by GKS.
- The only randomized trial of radiosurgery for GBM did not demonstrate a survival benefit.
Conclusions:
- GKS may offer a survival advantage as part of multimodal GBM treatment.
- Further investigation into GKS mechanisms and patient selection is warranted.
- Despite encouraging preliminary data, definitive evidence for GKS as a primary GBM treatment is lacking.